Ledger.Open graph →
SEC Form D · filed April 15, 2016

Centrexion Therapeutics Corp

Offering
—
Sold
$6.9M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
BALTIMORE, MD
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (23)

Isaac Blech · Baltimore, MDDirectorShengda L. Zan · Baltimore, MDDirectorGregg L. Beloff · Baltimore, MDExecJames N. Campbell · Baltimore, MDExec · DirectorKerrie L. Brady · Baltimore, MDExecArnold L. Oronsky · Baltimore, MDDirectorJeffrey B. Kindler · Baltimore, MDExecSol Barer · Baltimore, MDDirectorAbby Ross · Chicago, ILDirectorShana M. Ostrovitz · Boca Raton, FLDirectorDonald L. Dillingham · Oklahoma City, OKExecBrian K. Niles · Boca Raton, FLDirectorChuck Templeton · Chicago, ILExecEileen Murphy · Chicago, ILDirectorJoshua Tolman · Chicago, ILExec · DirectorJerry R. Masters · Parker, COExec · DirectorTheodore A. Klug · Bassett, NEExecDavid D. Gale · Bassett, NEExec · DirectorDennis S. Swanson · Bassett, NEDirectorDonald S. Allen · North Platte, NEExecWarren R. Arganbright · Valentine, NEDirectorRobert Van Doorn · Vancouver, British Columbia, CanadaDirectorAntonio Canton · Vancouver, British Columbia, CanadaExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗